UBS
SMI Gains as Fed Rate Hike Brings Relief; UBS Decision Deferred
Swiss shares post modest gains after the US Federal Reserve raised rates by 25 basis points as expected. UBS capital-rule debate resumes next week.
SMI rises 0.2% as Fed delivers; UBS gains, Rieter plunges after downgrade
The Swiss market extends its early-week gains following the Fed's expected 25-bp hike. Helvetia Baloise surges on strong H1 results while Rieter drops after a UBS downgrade to Sell.
SMI Edges Higher on Fed Relief; UBS Decision Delayed, Rieter Slumps on Downgrade
Swiss benchmark gains 0.2% as investors welcome Fed's resolute inflation stance; UBS advances ahead of capital-rule vote while Rieter plunges after downgrade to Sell.
Swiss Market Index holds gains amid Fed hike, UBS gains amid Ständerat vote
The SMI advances modestly as the Swiss market reacts to the Fed’s 25 bps rate hike and UBS’ capital rules vote, while Roche and Rieter face profit-taking pressures.
Swiss Market Index rises as UBS gains amid Fed rate hike, Helvetia Baloise outperforms
UBS gains after Ständerat approves stricter capital rules; Roche and Rieter face downgrades; oil prices ease amid Saudi export diversification efforts.
UBS Stock Continues Slide as Weak U.S. Bank Sentiment Weighs
UBS shares fell to 41.53 francs, down 7.2% from their recent 45-franc high, as Goldman Sachs warned of stronger-than-expected costs. Swiss capital-rule debate adds further uncertainty.
UBS Shares Extend Losses as Weak US Banks Weigh on Swiss Lender
UBS shares slid further Thursday as Goldman Sachs' warning dragged on bank sentiment, while Swiss policymakers face a key vote on capital rules.
Swiss Market Index rises; Roche downgraded, Rieter hit by UBS rating cut
Swiss equities mixed as SMI gains, but Roche and Rieter face downgrades; oil prices dip amid geopolitical uncertainty and Fed rate hike expectations.
FINMA reports stable supervised institutions despite rising global risks in 2025
Swiss financial regulator says banks and insurers held steady through geopolitical turbulence, but flagged liquidity gaps in 8.2% of bond funds under stress scenarios.
UBS secures softer capital rules, saving hundreds of millions annually
Swiss regulator approves partial use of AT1 bonds, easing UBS’s capital requirements amid post-Credit Suisse reforms
US markets open lower; SMI falls 1.2% with UBS leading declines
The SMI dropped 1.22% to 13,708.71 as oil prices near $108 and the 10-year Treasury yield hit 5.041% weighed on equities. UBS led losers in Switzerland.
UBS's Kunkel sees broadening rally, warns of three key risks
The UBS global family and institutional wealth CIO anticipates widening equity gains driven by earnings, while flagging oil shocks, AI monetisation doubts and fiscal pressures as top threats.
Swiss stocks fall as oil pressure hits UBS, Richemont; Adecco, Barry Callebaut rise
Swiss shares slipped midweek on oil prices and US weakness, with Novartis, UBS and Richemont under pressure while Adecco, DocMorris and Barry Callebaut moved sharply.
Swiss SMI set lower; 19 of 20 SMI stocks down, DocMorris and Barry Callebaut in focus
Swiss equities are seen lower before the open, with 19 of 20 SMI shares down; DocMorris falls on a new convertible bond while Barry Callebaut steadies on a calmer cocoa outlook.
US Futures Slip; SMI Tumbles 1.3% on Oil, Rates, Bank Woes
The SMI fell 1.3%, with UBS leading declines as Powell's 5.041% yield and Brent crude near $108 weigh on stocks.
SMI widens losses; UBS, Partners Group fall; Centiel gains
The Swiss benchmark fell 1.3% as UBS dropped 4%, Brent topped $107 and traders awaited the Fed decision; Centiel rose 7% on a plant acquisition.
UBS Shares Fall 4.7% After Bank of America Flags Flat Trading Revenues
UBS shares dropped as much as 4.7% to 41.31 francs after Bank of America CEO Brian Moynihan forecast relatively stable Q3 trading revenues, raising concerns about the Swiss bank's record trading performance.
Swiss stocks fall after open; UBS, Partners Group and SMG drop
SMI opens 0.55% lower as UBS and Partners Group fall, SMG drops after ownership changes, Centiel rises, and oil gains ahead of the Fed decision.
Swiss Economic Calendar: Data Releases, Earnings Due Sept 15-22
Switzerland’s weekly financial calendar features Austrian and Swiss inflation data, SNB balance-of-payments figures, and H1 earnings from Addex, Curatis, Newron and others.
SMI set lower as oil rises and AI-security fears pressure chip stocks
Swiss SMI is set to open 0.26% lower as Middle East tensions lift oil and AI-security concerns weigh on chip stocks, while the dollar gains against the franc.
Best-Performing Dividend ETFs Over the Past Decade: US and Swiss Comparisons
YCharts ranks three US dividend ETFs among the top performers of the past decade, while Swiss-listed funds from UBS and BlackRock offer lower-cost alternatives with concentrated SMI exposure.
SMI closes at session low as Novartis posts biggest daily loss ever
The Swiss benchmark fell 1.55% to 14,047, dragged by Novartis (-10.9%) after a Phase III study failure. UBS rose to a 19-year high above 45 francs.
Novartis trial miss drags Swiss SMI lower; Nestlé, Ascom gain
Novartis shares fell nearly 10% after Del-desiran missed a Phase III endpoint, pulling the SMI lower while Nestlé, Sandoz and Ascom gained and Brent approached $100.
Künzli CEO Roberto Martullo seeks Bally takeover amid bankruptcy
Swiss shoe maker Künzli's owner proposes buying the distressed Bally brand, its boutiques and production assets as the former luxury footwear group faces insolvency and a CHF 20 million debt pile.